share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

週三盤後交易時段，12只醫療保健類股走勢
Benzinga ·  2023/08/10 05:32

Gainers

獲勝者

  • Vistagen Therapeutics (NASDAQ:VTGN) stock rose 22.5% to $8.62 during Wednesday's after-market session. Trading volume for this security closed at 4.6 million, accounting for 394.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $68.8 million.
  • AIM ImmunoTech (AMEX:AIM) shares rose 11.69% to $0.64. The market value of their outstanding shares is at $30.7 million.
  • Tenon Medical (NASDAQ:TNON) shares moved upwards by 10.45% to $0.26. Tenon Medical's trading volume hit 156.5K shares by close, accounting for 23.3% of its average volume over the last 100 days. The company's market cap stands at $5.6 million. The company's, Q2 earnings came out yesterday.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 10.19% to $0.95. The market value of their outstanding shares is at $11.1 million.
  • PMV Pharma (NASDAQ:PMVP) stock increased by 10.13% to $9.55. The market value of their outstanding shares is at $437.1 million. As per the news, the Q2 earnings report came out today.
  • LogicMark (NASDAQ:LGMK) shares moved upwards by 9.31% to $2.7. The market value of their outstanding shares is at $3.4 million.
  • 維斯塔根 Therapeutics 納斯達克股票代碼：VTGN）股價在週三的盤後交易時段上漲了22.5％，至8.62美元。該證券的交易量收於460萬隻，佔其過去100天平均全日交易量的394.0％。他們已發行股票的市值爲6,880萬美元。
  • AIM 免疫科技 (AMEX: AIM) 股價上漲11.69％，至0.64美元。他們已發行股票的市值爲3,070萬美元。
  • 泰農醫療 納斯達克股票代碼：TNON）股價上漲10.45％，至0.26美元。收盤時，Tenon Medical的交易量達到15.65萬股，佔其過去100天平均成交量的23.3％。該公司的市值爲560萬美元。該公司第二季度業績於昨天公佈。
  • Virpax 製藥 納斯達克股票代碼：VRPX）的股價上漲了10.19％，至0.95美元。他們已發行股票的市值爲1,110萬美元。
  • PMV 製藥 納斯達克股票代碼：PMVP）的股票上漲了10.13％，至9.55美元。他們已發行股票的市值爲4.371億美元。根據消息，第二季度業績於今天發佈。
  • LogicMark 納斯達克股票代碼：LGMK）股價上漲9.31％，至2.7美元。他們已發行股票的市值爲340萬美元。

Losers

失敗者

  • Galera Therapeutics (NASDAQ:GRTX) stock declined by 83.2% to $0.38 during Wednesday's after-market session. Trading volume for this security closed at 8.6 million, accounting for 1034.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.1 million.
  • Organogenesis Hldgs (NASDAQ:ORGO) stock fell 41.0% to $2.0. At the close, Organogenesis Hldgs's trading volume reached 194.3K shares. This is 17.7% of its average volume over the last 100 days. The company's market cap stands at $262.5 million. As per the press release, Q2 earnings came out today.
  • Matinas BioPharma Hldgs (AMEX:MTNB) shares declined by 15.16% to $0.28. Today's trading volume for this security ended up closing at 153.6K shares, which is 32.0 percent of its average volume over the last 100 days. The company's market cap stands at $61.6 million. The company's, Q2 earnings came out today.
  • Infinity Pharmaceuticals (NASDAQ:INFI) shares decreased by 12.4% to $0.1. Infinity Pharmaceuticals's trading volume hit 2.3 million shares by close, accounting for 86.5% of its average volume over the last 100 days. The company's market cap stands at $9.0 million.
  • Akso Health Group (NASDAQ:AHG) shares declined by 11.88% to $0.32. The market value of their outstanding shares is at $7.3 million.
  • Aceragen (NASDAQ:ACGN) shares declined by 9.3% to $0.53. The company's market cap stands at $4.4 million. See Also:
  • Galera Therape 納斯達克股票代碼：GRTX）股價在週三的盤後交易時段下跌了83.2％，至0.38美元。該證券的交易量收於860萬隻，佔其過去100天平均全日交易量的1034.8％。他們已發行股票的市值爲1,610萬美元。
  • Organogenesis Hold 納斯達克股票代碼：ORGO）股價下跌41.0％，至2.0美元。收盤時，Organogenesis Hldgs的交易量達到19.43萬股。這是過去100天平均交易量的17.7％。該公司的市值爲2.625億美元。根據新聞稿，第二季度業績於今天公佈。
  • 馬蒂納斯生物製藥控股公司 (AMEX: MTNB) 股價下跌15.16％，至0.28美元。該證券今天的交易量最終收於153.6萬股，佔其過去100天平均交易量的32.0％。該公司的市值爲6160萬美元。該公司第二季度業績於今天公佈。
  • 無限制藥 納斯達克股票代碼：INFI）股價下跌12.4％，至0.1美元。截至收盤，Infinity Pharmicals的交易量達到230萬股，佔其過去100天平均交易量的86.5％。該公司的市值爲900萬美元。
  • Akso 健康集團 納斯達克股票代碼：AHG）股價下跌11.88％，至0.32美元。他們已發行股票的市值爲730萬美元。
  • Aceragen 納斯達克股票代碼：ACGN）股價下跌9.3％，至0.53美元。該公司的市值爲440萬美元。 另請參閱：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成，並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論